ADARx Pharmaceuticals, Inc. (ADRX)

ADARx Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

ADARx Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-87.87	-73.09	-46.36
Depreciation & Amortization	2.64	2.33	1.5
Share-Based Compensation	-	6.13	3.95
Other Operating Activities	-3.09	326.92	-7.65
Operating Cash Flow	-88.32	262.29	-48.56
Operating Cash Flow Growth	-	-	-

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Capital Expenditures	-1.89	-2.94	-0.46
Change in Investments	-	-206.99	39.97
Investing Cash Flow	81.02	-209.93	39.51

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Share Issuance / Repurchase	-	0.1	0.23
Financing Cash Flow	0.02	0.1	0.23

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	-7.16	52.48	-8.82

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-90.21	259.35	-49.02
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	-1472.37%	7519.66%	-